Cargando…

Prospective assessment of diagnostic efficacy and safety of Sonazoid(TM) and SonoVue(®) ultrasound contrast agents in patients with focal liver lesions

OBJECTIVES: To assess the respective diagnostic value of Sonazoid™ and SonoVue® for characterizing FLLs as benign or malignant and the corresponding safety. METHODS: This prospective Phase 3 study was conducted at 17 centres in China and Korea (May 2014 to April 2015); 424 patients (20 to 80 years)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Ke, Zhai, Hongyan, Jiang, Yuxin, Liang, Ping, Xu, Hui-Xiong, Du, Lianfang, Chou, Yi-Hong, Xie, Xiaoyan, Luo, YuKun, Lee, Young Joon, Lee, Jae Young, Hu, Bing, Luo, Baoming, Wang, Yi, Luan, Ying, Kalli, Christina, Chen, Kun, Wang, Wenping, Liang, Ja-Der
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Hepatobiliary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435522/ https://www.ncbi.nlm.nih.gov/pubmed/34136936 http://dx.doi.org/10.1007/s00261-021-03010-1

Ejemplares similares

Head-to-head comparison of Sonazoid and SonoVue in the diagnosis of hepatocellular carcinoma for patients at high risk
por: Huang, Jiayan, et al.
Publicado: (2023)

SonoVue(®) vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarcinoma?
por: Kotopoulis, Spiros, et al.
Publicado: (2022)

Contrast-enhanced ultrasonography of the liver using SonoVue
por: Ferraioli, Giovanna, et al.
Publicado: (2018)

Optimal Control of SonoVue Microbubbles to Estimate Hydrostatic Pressure
Publicado: (2019)

Safety of Lumason® (SonoVue®) in special populations and critically ill patients
por: Filippone, A., et al.
Publicado: (2023)

Targeted Delivery of Salusin‐α Into Rabbit Carotid Arterial Endothelium Using SonoVue
por: Wang, Yuxue, et al.
Publicado: (2021)

Sonazoid™ versus SonoVue(®) for Diagnosing Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound in At-Risk Individuals: A Prospective, Single-Center, Intraindividual, Noninferiority Study
por: Kang, Hyo-Jin, et al.
Publicado: (2022)

The Effect of Contrast Medium SonoVue(®) on the Electric Charge Density of Blood Cells
por: Petelska, Aneta D., et al.
Publicado: (2011)

Micro-Particle Image Velocimetry Investigation of Flow Fields of SonoVue Microbubbles Mediated by Ultrasound and Their Relationship With Delivery
por: Zou, Penglin, et al.
Publicado: (2020)

Adverse reactions after the use of SonoVue contrast agent: Characteristics and nursing care experience
por: Hu, Chenlu, et al.
Publicado: (2019)

Diagnostic Value of SonoVue Contrast-Enhanced Ultrasonography in Nipple Discharge Based on Artificial Intelligence
por: Guo, Ling
Publicado: (2021)

Microbubble contrast agent SonoVue: An efficient medium for the preoperative lymphatic mapping of thyroid carcinoma
por: Chen, Lei, et al.
Publicado: (2022)

Segurança do Agente de Contraste SF(6) (SonoVue(Ⓡ)) no Ecocardiograma sob Estresse Farmacológico
por: Furtado, Rogerio Gomes, et al.
Publicado: (2021)

miR-378 in combination with ultrasonic irradiation and SonoVue microbubbles transfection inhibits hepatoma cell growth
por: Wang, Jianjun, et al.
Publicado: (2020)

Comparison of the synergistic effect of lipid nanobubbles and SonoVue microbubbles for high intensity focused ultrasound thermal ablation of tumors
por: Yao, Yuanzhi, et al.
Publicado: (2016)

Diagnostic Value of Contrast-Enhanced Ultrasonography With SonoVue in the Differentiation of Benign and Malignant Breast Lesions: A Meta-Analysis
por: Lu, Jianghao, et al.
Publicado: (2020)

Ultrasonic irradiation and SonoVue microbubbles-mediated RNA interference targeting PRR11 inhibits breast cancer cells proliferation and metastasis, but promotes apoptosis
por: Luo, Hui, et al.
Publicado: (2020)

Effect of RNA Interference Targeting STAT3 Gene Combined with Ultrasonic Irradiation and SonoVue Microbubbles on Proliferation and Apoptosis in Keratinocytes of Psoriatic Lesions
por: Ran, Li-Wei, et al.
Publicado: (2018)

Contrast-enhanced ultrasound using SonoVue mixed with oral gastrointestinal contrast agent to evaluate esophageal hiatal hernia: Report of three cases and a literature review
por: Wang, Jing-Yu, et al.
Publicado: (2021)

Low-intensity pulsed ultrasound in combination with SonoVue induces cytotoxicity of human renal glomerular endothelial cells via repression of the ERK1/2 signaling pathway
por: Liu, Xiu, et al.
Publicado: (2018)

Gallbladder polyps growth rate is an independent risk factor for neoplastic polyps
por: Han, Ji Won, et al.
Publicado: (2022)

Delivery of miR-654-5p via SonoVue Microbubble Ultrasound Inhibits Proliferation, Migration, and Invasion of Vascular Smooth Muscle Cells and Arterial Thrombosis and Stenosis through Targeting TCF21
por: Wang, Tao, et al.
Publicado: (2022)

Thrombolysis for haemobilia‐induced biliary obstruction through a cholangiodrainage catheter
por: Wang, Xiaoze, et al.
Publicado: (2023)

Real-time virtual sonography-assisted radiofrequency ablation in liver tumors with conspicuous or inconspicuous images or peritumoral landmarks under ultrasonography
por: Huang, Hsin-Chih, et al.
Publicado: (2021)

Contrast-enhanced ultrasound for screening hepatocellular carcinoma: an implemented program at a semi-rural academic center
por: Motz, Victoria L., et al.
Publicado: (2021)

Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017
por: Javle, Milind, et al.
Publicado: (2022)

Inhibition of NAE‐dependent protein hyper‐NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease
por: Lee‐Law, Pui Y., et al.
Publicado: (2021)

Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
por: Saha, Supriya K., et al.
Publicado: (2016)

Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
por: Sanoff, Hanna K., et al.
Publicado: (2016)

Next‐Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma
por: Ikeda, Sadakatsu, et al.
Publicado: (2018)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges
por: Liu, Xiufeng, et al.
Publicado: (2019)

Nivolumab in Advanced Hepatocellular Carcinoma: Safety Profile and Select Treatment‐Related Adverse Events From the CheckMate 040 Study
por: Julien, Karen, et al.
Publicado: (2020)

Correlation of liver-to-spleen ratio, lung CT scores, clinical, and laboratory findings of COVID-19 patients with two consecutive CT scans
por: Guler, Ezgi, et al.
Publicado: (2020)

Feasibility and safety of bedside percutaneous biliary drainage in patients with severe cholangitis
por: Gupta, Pankaj, et al.
Publicado: (2020)

Higher frequency of hepatic steatosis at CT among COVID-19-positive patients
por: Medeiros, Augusto Kreling, et al.
Publicado: (2020)

CT of amebic liver abscess: different morphological types with different clinical features
por: Priyadarshi, Rajeev Nayan, et al.
Publicado: (2021)

The natural course of giant paraesophageal hernia and long-term outcomes following conservative management
por: Oude Nijhuis, Renske A B, et al.
Publicado: (2020)

Clinical management of patients with drug‐induced liver injury (DILI)
por: Björnsson, Einar S.
Publicado: (2021)

Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany
por: Labenz, Christian, et al.
Publicado: (2021)

Neoadjuvant Treatment with Angiogenesis‐Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study
por: Woei‐A‐Jin, F.J. Sherida H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9ehe785rffm98esrgm7ft52v2t